Universitätsklinikum Gießen und Marburg (UKGM)

OCT-assessment of scaffold resorption: analysis of strut intensity via the brs-resorb-index for poly-L-lactic acid bioresorbable vascular scaffolds (2018) Blachutzik F, Achenbach S, Tröbs M, Weissner M, Nef H, Schlundt C, Marwan M Conference contribution Early identification of bronchopulmonary dysplasia using novel biomarkers by proteomic screening (2018) Foerster K, Sass S, Ehrhardt H, Mous DS, Rottier RJ, Oak P, Schulze A, et al. Journal article Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter (2018) Nef HM, Abdel-Wahab M, Achenbach S, Joner M, Levenson B, Mehilli J, Moellmann H, et al. Journal article, Review article Correction: Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter (2018) Nef HM, Abdel-Wahab M, Achenbach S, Joner M, Levenson B, Mehilli J, Moellmann H, et al. Journal article, Erratum Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease. (2018) Burgmaier K, Kunzmann K, Ariceta G, Bergmann C, Buescher AK, Burgmaier M, Dursun I, et al. Journal article Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women (2018) Dittrich R, Kliesch S, Schuering A, Balcerek M, Baston-Buest DM, Beck R, Beckmann M, et al. Journal article Dual-Center, Dual-Platform Microrna Profiling Identifies Plasma Biomarkers of Adult Temporal Lobe Epilepsy (2018) Raoof R, Bauer S, El Naggar H, Brennan G, Hill T, Brindley E, Connolly N, et al. Conference contribution RECREATE: Treatment reality for mRCCpatients following first line Pazopanib therapy - a retrospective chart review (2018) Hegele A, Von Der Heyde E, Goebell P, Huebner A, Zengerling F, Klier J, Belz H, et al. Conference contribution Follow-up of bladder cancer. The right examinations at the right time (2018) Olbert P, Goebell P, Hegele A Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article